MTOR and non-small cell lung carcinoma: Another study by Shimizu et al. also supported that ASCT2 was significantly overexpressed in NSCLC, which correlated with advanced disease stage, lymphatic permeation, vascular invasion, increased cell proliferation, angiogenesis, and mTOR phosphorylation [195].